Lykos Therapeutics appoints Allison Rosenthal to lead the commercialization of its transformative mental health treatment platform.
Client: Lykos Therapeutics | Role: Chief Commercial Officer | Candidate: Allison Rosenthal
Recruiter: Beth Ehrgott, Managing Director
Overview
Lykos Therapeutics, a purpose-driven biopharmaceutical company pioneering novel mental health treatments, partnered with The Alexander Group, a global executive search firm, to recruit a Chief Commercial Officer. As Lykos prepared for a groundbreaking commercial launch, the company sought a strategic commercial leader with deep experience in CNS, global commercialization, and patient-centric go-to-market planning.
Key Leadership Need
Lykos’ Chief Commercial Officer would need to `build and scale the organization’s commercial operations, including marketing, market access, sales, distribution, and patient support. The ideal candidate would combine enterprise-level experience with a founder’s mindset—capable of translating science into market impact while navigating a fast-moving regulatory and cultural landscape.
The Alexander Group’s Approach
Managing Director Beth Ehrgott led a targeted search across global biotech and pharmaceutical leadership. The search focused on executives who have built successful commercialization strategies in CNS, neuropsychiatry, or similarly complex therapeutic areas.
Search priorities include:
- Experience leading commercialization in regulated and emerging markets.
- Proven ability to scale commercial teams and infrastructure from early stage to launch.
- Deep knowledge of the U.S. healthcare system, market access, and patient engagement strategy.
Allison Rosenthal emerges as the ideal fit with decades of experience at companies like Otsuka and Bristol-Myers Squibb, where she leads large-scale CNS commercial teams and advises executive leadership on launch strategy, brand positioning, and revenue growth.
Successful Placement and Impact
Allison Rosenthal joins Lykos Therapeutics as Chief Commercial Officer. She oversees commercialization strategy for the company’s groundbreaking therapeutic platform, working closely with the CEO, COO, and Board to bring a new mental health treatment model to market.
Immediate Impact:
- Leads go-to-market strategy across sales, access, marketing, and patient support.
- Builds commercial infrastructure to support rapid and sustainable growth.
- Partners with executive leadership on launch planning, stakeholder alignment, and scalability.
- Positions Lykos as a category-defining force in modern mental health care.
Insights from the Recruiter
“Allison has tremendous commercial leadership experience in psychiatry and mental health, and is the perfect cultural fit for the Lykos team with her warmth and contagious enthusiasm to bring psychedelic-assisted therapy across the finish line to those suffering [from] PTSD. She is and will continue to be an inspiring champion for all who struggle with mental health issues.”
– Beth Ehrgott, Managing Director, The Alexander Group
About Lykos Therapeutics
Lykos Therapeutics is a public benefit corporation dedicated to transforming mental health care through science-backed innovation. With a focus on developing breakthrough therapies in neuropsychiatry, Lykos combines rigorous research, ethical leadership, and patient-first commercialization.
About The Alexander Group
The Alexander Group is a global executive search firm based in Houston. With expertise spanning biotech, life sciences, healthcare, and mission-driven organizations, the firm helps high-growth companies recruit the transformative leaders who move science from bench to bedside.Bringing innovation to market starts with the right leadership. The Alexander Group helps build the teams that drive breakthrough science forward.
